Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
12/2010
12/15/2010EP2261203A1 Phenylcyclobutylamide derivatives and their stereoisomers, the preparing processes and the uses thereof
12/15/2010EP1756037B1 Amino alcohol derivatives and their activity as renin inhibitors
12/15/2010CN101918352A Inhibitors of 17beta-hydroxysteroid dehydrogenase
12/15/2010CN101914035A Method for preparing oxytetracycline hydrochloride
12/14/2010US7851642 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amide compound
12/14/2010US7851634 enzyme inhibitors such as N-(2-Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2-isopropyl-7-[3-(3-methoxypropyl)-1H-indol-5-ylmethyl]-8-methylnonanamide, used as hypotensive agents
12/14/2010US7851494 administering 5-[(4-(2,6-difluorobenzyloxy)phenyl)-methyl]-1H-tetrazole for the treatment of insulin resistance, diabetes, hyperlipemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
12/14/2010US7851460 such as 7-(2,4-difluorophenyl)sancycline, used for the treatment of bacterial infections in mammals
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/09/2010US20100311962 Agents For Magnetic Imaging Method
12/08/2010EP2257524A1 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
12/08/2010EP1848684B1 Ester-linked gemini surfactant compounds for use in gene therapy
12/08/2010CN101906055A Synthesis method of Nepafenac
12/08/2010CN101906053A 酰胺衍生物 Amide derivatives
12/07/2010US7846949 liver X receptors (LXR) modulators such as Tert-butyl 2-(2,4,6-trifluoro-N-(3-hydroxyphenyl benzamido)acetate, useful in the treatment of LXR-associated diseases such as cardiovascular disorders, inflammation and disorders of glucose metabolism such as insulin resistance and obesity
12/07/2010CA2427560C Alkynyl amides and their therapeutic applications
12/02/2010US20100305309 Nanodiamond particle complexes
12/02/2010US20100305077 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
12/02/2010US20100305072 Substituted Tetracycline Compounds
12/02/2010US20100303805 Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases
12/01/2010CN101903350A Aminobenzamide derivatives as useful agents for controlling animal parasites
11/2010
11/30/2010CA2477208C Substituted phenylalkanoic acid derivatives and use thereof
11/30/2010CA2460682C Ester compound and medical use thereof
11/25/2010US20100298593 Methoxyimino compounds and fungicide composition comprising same
11/25/2010US20100298568 Processes and intermediates for preparing steric compounds
11/25/2010US20100298402 Stilbene derivatives as pstat3/il-6 inhibitors
11/25/2010US20100298344 Polycationic Compounds And Uses Thereof
11/25/2010US20100298164 Structure-based approach to design of inhibitors of protein-processivity factor interactions
11/25/2010US20100297023 Lipid
11/24/2010EP2252579A2 Antibiotic compounds
11/24/2010EP2252578A1 Novel conjugates for treating neurodegenerative diseases and disorders
11/24/2010EP2252572A1 Method for preparing combretastatin
11/24/2010EP1280764B1 Inhibitors of histone deacetylase
11/24/2010CN101896456A Process for the production of 2-[4-(3- or 2-fluorobenzyloxy)benzylamino]propanamides with high purity degree
11/24/2010CN101896455A 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
11/24/2010CN101891647A Preparation method for ubenimex
11/23/2010US7838706 antimitotic; antitumor; ethylate 4-hydroxy-3-methoxybenzaldehyde with ethyl bromide to form the 4-ethoxy-; Wittig reaction with 3,4,5-trimethoxybenzyltriphenylphosphonium ylid; phosphorylation
11/23/2010US7838520 Inhibitors of histone deacetylase
11/23/2010CA2695551C Alternative dimerisation reagents for synthesis of iodixanol
11/18/2010WO2010132670A2 Pentacycline compounds
11/18/2010WO2010131922A2 Amide compound, preparation method thereof and pharmaceutical composition comprising same
11/18/2010WO2010131054A1 Redox drug derivatives
11/18/2010US20100292509 Vegfc production promoter
11/18/2010US20100292337 Polar Hydrophilic Prodrugs of Amphetamine and Other Stimulants and Processes for Making and Using the Same
11/18/2010US20100292336 Polar Hydrophilic Prodrugs and Non-Standard Amino Acid Conjugates of Amphetamine and Other Stimulants and Processes for Making and Using the Same
11/18/2010US20100292335 Use of organic compounds
11/18/2010US20100291622 Novel compound, process for production thereof, and use thereof
11/18/2010CA2762022A1 Redox drug derivatives
11/17/2010EP2251320A1 Crystalline form of tigecycline and processes for preparation thereof
11/17/2010EP1032377B1 Substituted 2-aminoacetamides and the use thereof
11/17/2010CN101888992A Contrast agents
11/17/2010CN101888991A Retinoid prodrug compound
11/17/2010CN101888858A Contrast agents
11/16/2010US7834013 Racemic-(trans)-2-[4-({[3-(phenyloxy)phenyl]methyl}ammonium)phenyl]cyclopropanecarboxylic acid; type II diabetes; G protein-coupled receptor 40 (GPR40) agonists
11/11/2010WO2010127928A1 Insecticidal compounds
11/11/2010WO2009141091A8 Novel [f-18] -labelled l-glutamic acid- and l-glutamine derivatives (i), use thereof and method for their production
11/11/2010US20100286353 Acetylene compound, salt thereof, condensate thereof, and composition thereof
11/11/2010US20100286197 Carboxamide Derivatives As Therapeutic Agents
11/11/2010CA2761241A1 Tetracycline compounds
11/11/2010CA2759592A1 Insecticidal compounds
11/10/2010EP2248807A1 N-phenyl-2-pyrimidine-amine derivatives
11/10/2010EP2247571A2 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use
11/10/2010EP1877365B1 Acetylene derivatives
11/10/2010CN1921891B Growth factor-binding compounds connecting with Calixarene
11/10/2010CN101176511B Method for removing or reducing residual medicament component in ursocycline medicine slag
11/09/2010US7829736 Refluxing propanephosphonic acid with acetic anhydride to produce 2,4,6-tripropyl-[1,3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide; prevents immediate polymerization cyclic propanephosphonic anhydrides
11/09/2010US7829669 Catalytically active recombinant memapsin and methods of use thereof
11/09/2010US7829521 Esters of abetaine glycine having a sulfonate or hydroxy anion produced by reaction of the glycine betaine with a sulfonic acid and an alcohol or a fattyamine derived from vegetable oils; foaming agents; shampoos; liquid soap, bath foam, shower gel simplification
11/09/2010CA2161684C Bioactive and/or targeted dendrimer conjugates
11/04/2010WO2010126607A2 Synthesis of tetracyclines and intermediates thereto
11/04/2010US20100280270 Process for the Prepartion of Iosimenol
11/04/2010US20100280108 Antitumoral Compounds
11/04/2010US20100279959 Medium-Chain Length Fatty Acids, Glycerides and Analogues as Neutrophil Survival and Activation Factors
11/04/2010US20100278730 Non-Invasive Molecular Imaging of Cellular Histone Deacetylase Substrate Using Magnetic Resonance Spectroscopy (MRS) or Positron Emission Tomography (PET)
11/04/2010CA2760611A1 Dual-action inhibitors and methods of using same
11/04/2010CA2760562A1 Dual mechanism inhibitors for the treatment of disease
11/03/2010EP2246323A1 Menthylcarboxamides and their use as cooling agents
11/03/2010EP2245004A2 Contrast agents
11/03/2010EP2245002A1 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
11/03/2010EP1496838B1 Substituted amides
11/03/2010CN1615295B Compounds for treatment of inflammation, diabetes and related disorders
11/02/2010US7825278 Central nervous system disorders; gamma aminobutyric acid (GABA) receptor complex modulators
11/02/2010US7825247 an N-phenyl-4-(4-methyl-piperazin-1-ylmethyl)-benzamide claimed intermediate easily prepared by amidation of the aniline and the benzoic acid; reaction with a 2-aminopyrimidine to produce antitumor tyrosine kinase inhibitor
11/02/2010US7825105 such as 3,10-Dibenzyloxyminocycline, used to treat bacterial infections and neoplasms, as well as blocking tetracycline efflux and modulation of gene expression
11/02/2010CA2400167C Insecticidal anthranilamides
10/2010
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010WO2009141090A8 {f-19} -labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them
10/28/2010US20100274050 Solid milnacipran and process for the preparation of the same
10/28/2010US20100274027 Organic compounds
10/28/2010US20100273694 Surfactant composition method for production thereof and cosmetic comprising said composition
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/27/2010CN1585633B Phenethanolamine derivatives for treatment of respiratory diseases
10/27/2010CN101870664A Preparation method of 4-amino-benzoyl formic-N-(4-amino-benzoyl formic) amine
10/26/2010US7820641 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy
10/21/2010WO2010059967A3 Amide inhibitors of renin
10/21/2010US20100267946 Prodrugs of gaba analogs, compositions and uses thereof
10/21/2010US20100267834 Methods and pharmaceutical compositions for differentially altering gene expression to provide neuroprotection for the animal central nervous system against the effects of ischemia, neurodegeneration, trauma and metal poisoning
10/21/2010US20100267781 Naphthalene-based inhibitors of anti-apoptotic proteins
10/21/2010US20100267780 Bicyclic aryl and heteroaryl receptor modulators
10/20/2010EP2240434A1 2-phenyl phenoxyacetic acids useful for treating inflammatory disorders
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 162